In addition, pharmacological inhibitors of key players in breast cancer cells Ca2+ signaling [22], ORAI and TRPC, were used to identify a potential Ca2+ pathway in which NNAT modulates Ca2+ levels. The gene discussed is NNAT; the disease is breast carcinoma.